UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325
Home » Archive of numbers » 2023 » Volume 31, issue 1 (114) » FEATURES OF PRIMARY PSYCHOPATHOLOGICAL DISORDERS DUE TO CORONAVIRUS DISEASE COVID-19

FEATURES OF PRIMARY PSYCHOPATHOLOGICAL DISORDERS DUE TO CORONAVIRUS DISEASE COVID-19

Authors

Type of Article

  • Scientific Article

In the Section

  • DIAGNOSIS AND TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND DRUG-RELATED DISORDERS

Key words

Index UDK:
  • 616.9-036.4-07-08:616.89-06

Abstract

The purpose of the study was to study the features of primary mental disorders that arose as a result of coronavirus disease.

In order to realize the goal of the study in the borderline psychiatry of the "INPN of NAMS of Ukraine" SI, 97 patients were examined for the first time psychic disorders suffered from Covid-19 and were exposed to the Sars-CV-2 pandemic stressors. The diagnosis was made taking into account the criteria of ICD-10 (F32.0 — F32.2 — 34 patients, F40 — F45—32 patients, F06.3 — F06.6 — 31 patients).

It is established that the surveyed patients with neurotic, stress, and somatoform disorders indicators of objective and subjective assessment of the severity of anxiety indicate the importance for patients with this group of personal assessment of what is happening to them. The indicators of depression in these patients corresponded to “light” and “moderate level” — the average score in the group was 20.16 points. The overall level of depression in patients with depressive episodes (F32.0 — F32.2) and in patients with mental disorders of organic genesis (F06.3 — F06.6), on average, in groups corresponded to “moderate” depression level — average points on the MADRS scale. and 23.04 points respectively. For patients with Covid-19, anxiety disorders of varying intensity are characteristic. The highest alarm rates were observed in the group of neurotic patients, related to stress and somatoform disorders, which on average in the group correspond to a moderate level ((27.92 ± 3.42) points). The intensity of anxiety in patients with depressive episodes and mental disorders of organic genesis was in the range from mild to moderate ((23.09 ± 2.86) points and (24.58 ± 3.19) points, respectively). In the structure of anxiety disorders in patients with neurotic, stress, and somatoform disorders, somatic and vegetative symptoms prevail, significant differences are established between groups of patients with neurotic, stress, and somatoform disorders and patients with depressive episodes. ((1.56 ± 0.31) points and (0.39 ± 0.22) respectively, p ≤ 0.05), vegetative symptoms ((2.24 ± 0.34) points and (1,12 ± 0.27), respectively, p ≤ 0.01).

Pages

  • 60-69

Year / Issue

Download PDF

References

  1. Mental health outcomes of the COVID-19 pandemic  / Talevi D., Socci V., Carai M. [et  ]  // Riv  Psichiatr. 2020 MayJun; 55(3): 137—144. DOI: https://doi.https://doi.org/10.1708/3382.33569.
  2. Sher L. The impact of the covid-19 pandemic on suicide rates. QJM: An International Journal of Medicine. 2020; 113 (10): 707—712. DOI: https://doi. https://doi.org/10.1093/qjmed/hcaa202.
  3. WHO Coronavirus (COVID-19), Dashboard, 2023. DOI: https://covid19.who.int/.
  4. United Nations. Policy Brief: COVID-19 and the Need for Action on Mental Health. May  URI: https://unsdg.un.org/sites/default/files/2020-05/UN-Policy-Brief-COVID-19-and-mental-health.pdf (Accessed on July 05,2020).
  5. Vindegaard N. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence  / N. Vindegaard, M. E. Benros // Brain Behav Immun. 2020 Oct; 89: 531—542. DOI: https://doi.10.1016/j.bbi.2020.05.048.
  6. Suicidal Ideation Among Individuals Who Have Purchased Firearms During COVID-19 / Anestis, M. D., Bond, A. E., Daruwala, S. E. [et al.] // American Journal of Preventive Medicine. 2021 Mar; 60(3), 311—317. DOI: https://doi.org/10.1016/j.amepre.2020.10.01.
  7. The role of  the COVID-19 pandemic as  a  risk factor for suicide: What is  its impact on  the public mental health state today? / Aquila, I., Sacco, M. A., Ricci, C. [et al.] // Psychological Trauma: Theory, Research, Practice, and Policy. 2020 Aug; 12(S1), S120—S122. DOI: https://doi.org/10.1037/tra0000616.
  8. Suicidal Behaviours During Covid-19 Pandemic: A Review / [Barberis N., Cannavò M., Cuzzocrea F., Verrastro V.] // Clin Neuropsychiatry. 2022 Apr; 19(2): 84—96. DOI:  https://doi.org/10.36131/cnfioritieditore20220202.
  9. Xiang Y. T. Joint International Collaboration to  Combat Mental Health Challenges During the Coronavirus Disease 2019 Pandemic  / Y. T.  Xiang, Y.  Jin, T.  Cheung  // JAMA Psychiatry. 2020; 77: 989. DOI: https://doi.org/10.1001/jamapsychiatry.2020.1057.
  10. Galea S. The Mental Health Consequences of COVID-19 and Physical Distancing: The Need for Prevention and Early Intervention / S.  Galea, R.    Merchant, N.  Lurie  // JAMA Intern Med. 2020; 180(6): 817—818. DOI: https://doi.org/10.1001/jamainternmed.2020.1562.
  11. Reger M. A. Suicide Mortality and Coronavirus Disease 2019-A Perfect Storm? / M. A. Reger, I. H. Stanley, T. E. Joiner // JAMA Psychiatry. 2020; 77(11): 1093—1094. DOI: https://doi.org/10.1001/jamapsychiatry.2020.1060.
  12. The psychological impact of quarantine and how to reduce it: rapid review of the evidence / Brooks S. K., Webster R. K., Smith L. E. [et al.] // Lancet. 2020. Vol. 395, Issue 10227. P. 912— 920. DOI: https://doi.org/10.1016/S0140-6736(20)30460-8.
  13. Pfefferbaum B. Mental Health and the Covid-19 Pandemic / B. Pfefferbaum, C. S. North // N Engl J Med. 2020; 383(6): 510—512. DOI: https://doi.org/10.1056/NEJMp2008017.
  14. Neurological and psychiatric risk trajectories after SARSCoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients / Taquet M., Sillett R., Zhu L. [et al.] // Lancet Psychiatry. 2022. Vol. 9, Issue 10, P. 815—827. DOI: https://doi.org/10.1016/S2215-0366(22)00260-7.
  15. Mental Health and COVID-19: Early evidence of the pandemic’s impact. Geneva: World Health Organization: Scientific brief, 2 March 2022. URI: https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Mental_health-2022.1.
  16. New WHO prevalence estimates of mental disorders in conflict settings: a  systematic review and meta-analysis  / Charlson, F., van Ommeren M., Flaxman A. [et al.] // Lancet. 2019; 394(10194): 240—248. DOI: https://doi.org/10.1016/S0140-6736(19)30934-1.
  17. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 / Huang, Y., Yang, C., Xu, Xf. [et al.] // Acta Pharmacol Sin. 2020. 41, 1141—1149. DOI: https://www.nature.com/articles/s41401-020-0485-4.
  18. Dosvid perezhyvannia pandemii COVID-19: dystantsiini psykholohichni doslidzhennia, dystantsiina psykholohichna pidtrymka : materialy onlain-seminariv 23 kvitnia 2020 roku «Dosvid karantynu: dystantsiina psykholohichna dopomoha i pidtrymka» ta 15 travnia 2020 roku «Dystantsiini psykholohichni doslidzhennia v umovakh pandemii Covid-19 i karantynu». Kyiv, 2020. 68 s. URI: https://ispp.org.ua/wp-content/uploads/Static/dosvid_onl-sem_23-04-20_and_15-05-20_ncov19.pdf.

Journal’s Indexing:

UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine

ДУ «ІНПН імені
П.В. ВОЛОШИНА
НАМН УКРАЇНИ»